ResMed, Inc. (RMD)
252.87
-2.45
(-0.96%)
USD |
NYSE |
Mar 06, 16:00
252.88
+0.01
(+0.00%)
Pre-Market: 20:00
ResMed Cash from Investing (Annual) : -200.04M for June 30, 2025
Cash from Investing (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Annual) Benchmarks
| Boston Scientific Corp. | -2.64B |
| Abbott Laboratories | -2.422B |
| Baxter International, Inc. | 2.841B |
| Stryker Corp. | -4.866B |
| Insulet Corp. | -222.70M |